June 25, 2026 03:21 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Kolkata: Taratala warehouse roof collapses | Indian Army's Trishakti Corps restores lifeline connectivity in North Bengal between Siliguri and Mirik | 19 million barrels flow through Strait of Hormuz, Trump declares oil prices are falling | No Hindi, no NEET: Vijay reignites Tamil Nadu's biggest political flashpoints | Messi creates World Cup history with record-breaking double; Mbappe equals Klose's mark hours later | Tech giant Oracle slashes 21,000 jobs while betting big on AI | 'Italy and I never beg': Meloni fires back at Trump over G7 photo claim | No more 'brother': Stalin's formal birthday greeting to Rahul reflects deepening rift | TMC seeks disqualification of 20 rebel MPs, Abhishek says 'membership should go' | Nara Lokesh pitches Andhra Pradesh as investment hub during Kolkata visit, sets $2.4 trillion economy goal
Covaxin | WHO Approval
Image Credit: UNICEF

Chinese vax took longer than COVAXIN to get approval, says WHO

| @indiablooms | Nov 04, 2021, at 06:20 am

New Delhi/IBNS: Covaxin did not take the longest to get the World Health Organization's (WHO) approval for Emergency Use Listing, according to Chief Scientist Dr Soumya Swaminathan.

Dismissing criticisms that the UN health body held up the approval to India-made Covaxin but readily cleared Chinese jabs, she said China-made Sinopharm and Sinovac vaccines took between 150-165 days to secure the WHO's approval, reported NDTV.

On average vaccines were given Emergency Use Listing approval in 50-60 days but some took up to 165 days.

"Covaxin is somewhere in the middle, it took somewhere between 90 and 100 days," Dr Swaminathan said.

The WHO panel tasked with clearing vaccines for Emergency Use Listing met last week and sought more information. "The committee met again today and were very satisfied," she said.

She said there are 13 more vaccines that are still awaiting the global health body's approval.

Since WHO Emergency Use Listed vaccines are a benchmark of safety and efficacy, many countries accept them, she said, adding that the clearance would have a significant impact on India's travel plans.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.